No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:37599200-37621800 |
Weak transcription |
NHLF |
lung
|
2 |
chr6:37612600-37619800 |
Weak transcription |
Brain Cingulate Gyrus |
brain
|
3 |
chr6:37614200-37621800 |
Weak transcription |
Aorta |
Aorta
|
4 |
chr6:37615800-37617400 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
5 |
chr6:37615800-37617400 |
Flanking Active TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
6 |
chr6:37616000-37617400 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
7 |
chr6:37616000-37618000 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
8 |
chr6:37616000-37618200 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
9 |
chr6:37616000-37618400 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
10 |
chr6:37616200-37617400 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
11 |
chr6:37616200-37617400 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
12 |
chr6:37616200-37618200 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
13 |
chr6:37616200-37618200 |
Enhancers |
Pancreas |
Pancrea
|
14 |
chr6:37616400-37617400 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
15 |
chr6:37616400-37618000 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
16 |
chr6:37616400-37618200 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
17 |
chr6:37616400-37618200 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
18 |
chr6:37616600-37617400 |
Enhancers |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
19 |
chr6:37616800-37617400 |
Bivalent Enhancer |
Primary T helper cells PMA-I stimulated |
--
|
20 |
chr6:37616800-37617400 |
Bivalent Enhancer |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
21 |
chr6:37616800-37617600 |
Bivalent Enhancer |
Duodenum Smooth Muscle |
Duodenum
|
22 |
chr6:37616800-37619600 |
Weak transcription |
Brain Substantia Nigra |
brain
|
23 |
chr6:37617000-37617400 |
Bivalent Enhancer |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
24 |
chr6:37617000-37617800 |
Enhancers |
Primary T helper naive cells fromperipheralblood |
blood
|
25 |
chr6:37617000-37617800 |
Weak transcription |
Liver |
Liver
|
26 |
chr6:37617000-37617800 |
Enhancers |
Gastric |
stomach
|
27 |
chr6:37617000-37618000 |
Bivalent Enhancer |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
28 |
chr6:37617000-37618400 |
Bivalent Enhancer |
Fetal Brain Male |
brain
|
29 |
chr6:37617000-37620200 |
Weak transcription |
Brain Dorsolateral Prefrontal Cortex |
brain
|
30 |
chr6:37617200-37617400 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
31 |
chr6:37617200-37617400 |
Bivalent/Poised TSS |
ES-UCSF4 Cell Line |
embryonic stem cell
|
32 |
chr6:37617200-37617400 |
Bivalent Enhancer |
Placenta Amnion |
Placenta Amnion
|
33 |
chr6:37617200-37617400 |
Bivalent Enhancer |
Right Ventricle |
heart
|
34 |
chr6:37617200-37617600 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
35 |
chr6:37617200-37617600 |
Bivalent Enhancer |
Fetal Brain Female |
brain
|
36 |
chr6:37617200-37617800 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
37 |
chr6:37617200-37619600 |
Weak transcription |
Brain Anterior Caudate |
brain
|
38 |
chr6:37617200-37619600 |
Weak transcription |
Ovary |
ovary
|
39 |
chr6:37617200-37619600 |
Weak transcription |
Right Atrium |
heart
|
40 |
chr6:37617200-37621600 |
Weak transcription |
Esophagus |
oesophagus
|
41 |
chr6:37617200-37622400 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|